» Articles » PMID: 33738254

The /miR-491 Axis Modulates Papillary Thyroid Cancer Invasion and Metastasis Through TGM2/NFκb/FN1 Signaling

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Mar 19
PMID 33738254
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

NEAT1 (nuclear paraspeckle assembly transcript 1) is an oncogenic long non-coding RNA (lncRNA) that facilitates tumorigenesis in multiple cancers. In papillary thyroid cancer (PTC), the molecular mechanism by which affects invasion and metastasis remains elusive. RNA sequencing was used to discover differentially expressed downstream genes. Protein and RNA expression analyses and immunohistochemistry detected the expression of , Transglutaminase 2 (TGM2), and microRNA-491 (miR-491) among PTC and non-cancerous tissues. Transwell and wound healing assays, and a mouse model of lung metastasis were used for further functional analyses. Bioinformatics was performed to predict miRNAs binding to both and . Rescue experiments and dual-luciferase reporter assays were performed. In PTC tissues, expression was markedly increased and regulated TGM2 expression. TGM2 was overexpressed in PTC, correlating positively with exthyroidal extension and lymph node metastasis. knockdown significantly inhibited invasion and metastasis. sponged miR-491, acting as a competing endogenous RNA to regulate expression. Fibronectin 1 (FN1) was predicted as a TGM2 target. TGM2 could transcriptionally activate FN1 by promoting nuclear factor kappa B (NFκb) p65 nuclear translocation, ultimately promoting PTC invasion/metastasis. These findings identify that sponges miR-491 to regulate TGM2 expression. TGM2 activates FN1 NFκb to promote PTC invasion and metastasis.

Citing Articles

A comprehensive analysis to reveal the underlying molecular mechanisms of natural killer cell in thyroid carcinoma based on single-cell RNA sequencing data.

Li X, Wang K, Liu J, Li Y Discov Oncol. 2025; 16(1):44.

PMID: 39808350 PMC: 11732816. DOI: 10.1007/s12672-025-01779-x.


Proteomic Analysis of Tissue Proteins Related to Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.

Zhang Q, Cao Z, Wang Y, Wu H, Zhang Z, Liu Z J Proteome Res. 2024; 24(1):256-267.

PMID: 39600146 PMC: 11705366. DOI: 10.1021/acs.jproteome.4c00737.


miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer.

Jin S, Wang W, Xu X, Yu Z, Feng Z, Xie J Acta Biochim Biophys Sin (Shanghai). 2024; 56(5):740-752.

PMID: 38477044 PMC: 11177115. DOI: 10.3724/abbs.2024009.


Novel role of lncRNAs regulatory network in papillary thyroid cancer.

Su Y, Mei L, Jiang T, Wang Z, Ji Y Biochem Biophys Rep. 2024; 38:101674.

PMID: 38440062 PMC: 10909982. DOI: 10.1016/j.bbrep.2024.101674.


HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.

Ma S, Wang J, Cui Z, Yang X, Cui X, Li X Sci Rep. 2024; 14(1):3870.

PMID: 38365849 PMC: 10873328. DOI: 10.1038/s41598-024-53854-y.


References
1.
Sun W, Lan X, Zhang H, Wang Z, Dong W, He L . NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer. Cell Death Dis. 2018; 9(3):380. PMC: 5841310. DOI: 10.1038/s41419-018-0418-z. View

2.
Leivonen S, Sahlberg K, Makela R, Due E, Kallioniemi O, Borresen-Dale A . High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth. Mol Oncol. 2013; 8(1):93-104. PMC: 5528509. DOI: 10.1016/j.molonc.2013.10.001. View

3.
Kim S . Transglutaminase 2 in inflammation. Front Biosci. 2006; 11:3026-35. DOI: 10.2741/2030. View

4.
Davies L, Welch H . Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014; 140(4):317-22. DOI: 10.1001/jamaoto.2014.1. View

5.
Yu P, Wang Y, Lv W, Kou D, Hu H, Guo S . LncRNA NEAT1/miR-1224/KLF3 contributes to cell proliferation, apoptosis and invasion in lung cancer. Eur Rev Med Pharmacol Sci. 2019; 23(19):8403-8410. DOI: 10.26355/eurrev_201910_19151. View